Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RX1 | P51575 | 11/20 | 0.44 |
| ▸ | TMPRSS4 | Q9NRS4 | 6/20 | 0.44 |
| ▸ | P2RX4 | Q99571 | 5/20 | 0.44 |
| ▸ | P2RX7 | Q99572 | 5/20 | 0.44 |
| ▸ | KCNMA1 | Q12791 | 1/20 | 0.40 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.39 |
| ▸ | STK39 | Q9UEW8 | 1/20 | 0.38 |
| ▸ | EGFR | P00533 | 1/20 | 0.38 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.38 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.37 |
| ▸ | SORT1 | Q99523 | 1/20 | 0.37 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | CRHBP | P24387 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13014189 | 0.80 | LMNA (0.47) | P2RX1P2RX4P2RX7KCNMA1MEN1 | |
| SCHEMBL5474018 | 0.80 | LMNA (0.47) | P2RX1P2RX4P2RX7KCNMA1MEN1 | |
| SCHEMBL116427 | 0.77 | PARK7 (0.48) | P2RX1TMPRSS4P2RX4P2RX7KCNMA1 | |
| SCHEMBL353264 | 0.75 | P2RX1 (0.46) | P2RX1KCNMA1MEN1KMT2ANPC1 | |
| SCHEMBL13014489 | 0.74 | KMT2A (0.50) | MEN1KMT2ANPC1RAB9A | |
| SCHEMBL117369 | 0.73 | P2RX1 (0.39) | P2RX1TMPRSS4P2RX4P2RX7KCNMA1 | |
| SCHEMBL23303570 | 0.73 | P2RX1 (0.60) | P2RX1TMPRSS4P2RX4P2RX7TRPV1 | |
| SCHEMBL4928355 | 0.73 | P2RX1 (0.76) | P2RX1TMPRSS4P2RX4P2RX7P2RX3 | |
| SCHEMBL353219 | 0.71 | PRKCI (0.35) | P2RX7MEN1KMT2ANPC1RAB9A | |
| SCHEMBL9329716 | 0.70 | TRPV1 (0.61) | P2RX1TMPRSS4P2RX4P2RX7KCNMA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2424850-A1 | BENZAMIDE AND NAPHTHAMIDE DERIVATIVES INHIBITING NUCLEAR FACTOR- KAP PA (B) - (NF-KB) | Profectus Biosciences, Inc. (US) | 2012-03-07 | — | — | EP | disclosed |
| US-20120046357-A1 | Benzamide and Napthamide Derivatives Inhibiting Nuclear Factor-Kappa (B) - (NK-kB) | PROFECTUS BIOSCIENCES, INC. (US) | 2012-02-23 | — | — | US | disclosed |
| WO-2010127058-A1 | BENZAMIDE AND NAPHTHAMIDE DERIVATIVES INHIBITING NUCLEAR FACTOR- KAP PA (B) - (NF-KB) | PROFECTUS BIOSCIENCES, INC. (US) | 2010-11-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120046357-A1 | Benzamide and Napthamide Derivatives Inhibiting Nuclear Factor-Kappa (B) - (NK-kB) | NFKBIA, IKBKB, NFKB1 | P2RX1 855/4885TMPRSS4 2798/4885P2RX4 1080/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.